BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹1,176 Cr | ₹1,136 Cr | ₹948 Cr | ₹844 Cr | ₹700 Cr |
What is the latest Contingent Liabilities ratio of BIOCON ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹1,176 Cr |
Mar2024 | ₹1,136 Cr |
Mar2023 | ₹948 Cr |
Mar2022 | ₹844 Cr |
Mar2021 | ₹700 Cr |
How is Contingent Liabilities of BIOCON Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹1,176 Cr | 3.57 | |
Mar2024 | ₹1,136 Cr | 19.81 | |
Mar2023 | ₹948 Cr | 12.25 | |
Mar2022 | ₹844 Cr | 20.63 | |
Mar2021 | ₹700 Cr | - |
Compare Contingent Liabilities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹48,693.5 Cr | 4.7% | -8.9% | 6.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | 4.7% |
-8.9% |
6.9% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses